Literature DB >> 23337213

Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

Daniel Serrano1, Aubrey N Manack, Michael L Reed, Dawn C Buse, Sepideh F Varon, Richard B Lipton.   

Abstract

OBJECTIVE: To quantify the cost differences and predictors of lost productive time (LPT) in persons with chronic migraine (CM) and episodic migraine (EM).
METHODS: The American Migraine Prevalence and Prevention (AMPP) study is a US national longitudinal survey of severe headache. Cost estimates were obtained via U.S. Census income data. To elucidate the unique predictors of LPT, the optimal distribution for modeling was determined. Zero inflation models for LPT were predicted from sociodemographics, headache features, characteristics and disability, medication use, and depression. The interaction between headache status and age was the primary effect of interest.
RESULTS: The eligible sample included 6329 persons with EM and 374 persons with CM. Men with CM aged 45 to 54 years cost employers nearly $200 per week more than do their EM counterparts. Likewise, for women, costs were higher for CM, with the cost differential between EM and CM being $90 per week. After comprehensive adjustment, increases in LPT with age were significantly higher in CM than in EM (rate ratio 1.03; 95% confidence interval 1.01-1.05). When age was recoded to a decade, metric rates of LPT increased 25% more per decade for CM than for EM (rate ratio 1.25; 95% confidence interval 1.004-1.5).
CONCLUSIONS: LPT is more costly and increases more rapidly for those with CM than for those with EM as age increases.
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23337213     DOI: 10.1016/j.jval.2012.08.2212

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  37 in total

1.  Quality improvement in neurology: primary headache quality measures.

Authors:  Stephen Ross; Eric Wall; Becky Schierman; J Mark Bailey; Eric Cheng; Charles Flippen; Shannon Petersen; Amy Sanders; David Seidenwurm; M Cristina Victorio
Journal:  Neurology       Date:  2015-01-13       Impact factor: 9.910

2.  Introduction to the special section: sustainability of work with chronic health conditions.

Authors:  William S Shaw; Torill H Tveito; Cécile R L Boot
Journal:  J Occup Rehabil       Date:  2013-06

3.  Productivity costs in patients with refractory chronic rhinosinusitis.

Authors:  Luke Rudmik; Timothy L Smith; Rodney J Schlosser; Peter H Hwang; Jess C Mace; Zachary M Soler
Journal:  Laryngoscope       Date:  2014-03-11       Impact factor: 3.325

4.  Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache Center.

Authors:  Elizabeth K Seng; Dawn C Buse; Jaclyn E Klepper; Sarah J Mayson; Amy S Grinberg; Brian M Grosberg; Jelena M Pavlovic; Matthew S Robbins; Sarah E Vollbracht; Richard B Lipton
Journal:  Headache       Date:  2017-01-31       Impact factor: 5.887

5.  Importance of Pain Acceptance in Relation to Headache Disability and Pain Interference in Women With Migraine and Overweight/Obesity.

Authors:  Jason Lillis; J Graham Thomas; Elizabeth K Seng; Richard B Lipton; Jelena M Pavlović; Lucille Rathier; Julie Roth; Kevin C O'Leary; Dale S Bond
Journal:  Headache       Date:  2017-03-13       Impact factor: 5.887

6.  Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Authors:  Simona Lattanzi; Francesco Brigo; Eugen Trinka; Fabrizio Vernieri; Tommaso Corradetti; Mauro Dobran; Mauro Silvestrini
Journal:  Drugs       Date:  2019-03       Impact factor: 9.546

Review 7.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

8.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

9.  The Association of Changes in Pain Acceptance and Headache-Related Disability.

Authors:  Jason Lillis; J Graham Thomas; Richard B Lipton; Lucille Rathier; Julie Roth; Jelena Pavlovic; Kevin C O'Leary; Dale S Bond
Journal:  Ann Behav Med       Date:  2019-06-04

10.  The serum level of inflammatory markers in chronic and episodic migraine: a case-control study.

Authors:  Fahimeh Martami; Soodeh Razeghi Jahromi; Mansoureh Togha; Zeinab Ghorbani; Maryam Seifishahpar; Atoosa Saidpour
Journal:  Neurol Sci       Date:  2018-07-15       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.